Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Dec;18(12):1268-1278.
doi: 10.1111/jch.12855. Epub 2016 Jun 1.

Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis

Tianqiang Qin et al. J Clin Hypertens (Greenwich). 2016 Dec.

Abstract

The aim of this study was to assess the prognostic value of hyperuricemia in patients with established hypertension by systematic review and meta-analysis of cohort studies. MEDLINE, Embase, and the Chinese Biomedical Literature Database were searched through January 2015. Seventeen cohort studies were included and their methodological quality was moderate to high, with Newcastle-Ottawa Scale scores ranging from 6 to 9. Random-effects model meta-analyses showed that in terms of adjusted categorical data, hyperuricemia significantly correlated with cardiovascular diseases in hypertensive patients (hazard ratio [HR], 1.51; 95% confidence interval [CI], 1.13-2.03), all-cause mortality (HR, 1.12; 95%CI, 1.02-1.23), and diabetes (HR, 1.84; 95% CI, 1.02-3.30) but not with stroke (HR, 0.85; 95%CI, 0.57-1.27); while, in terms of adjusted continuous data, the corresponding pooled HRs were 1.17 (95% CI, 1.07-1.27), 1.05 (95% CI, 0.98-1.13), 1.28 (95% CI, 1.18-1.38), and 1.06 (95% CI, 0.98-1.16), respectively. The findings of our meta-analysis suggest that hyperuricemia could slightly increase the risk of cardiovascular diseases and diabetes in patients with hypertension.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of study selection.
Figure 2
Figure 2
Hyperuricemia and risk of cardiovascular disease in hypertensive patients from adjusted data. HR indicates hazard ratio; CI, confidence interval.
Figure 3
Figure 3
Hyperuricemia and all‐cause mortality in hypertensive patients from adjusted data. HR indicates hazard ratio; CI, confidence interval.
Figure 4
Figure 4
Hyperuricemia and risk of diabetes in hypertensive patients from adjusted data. HR indicates hazard ratio; CI, confidence interval.

References

    1. Wu XW, Muzny DM, Lee CC, et al. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34:78–84. - PubMed
    1. Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol. 1985;121:11–18. - PubMed
    1. Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow‐up Study. Am J Epidemiol. 1995;141:637–644. - PubMed
    1. World Health Organization . Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
    1. Viazzi F, Parodi D, Leoncini G, et al. Serum uric acid and target organ damage in primary hypertension. Hypertension. 2005;45:991–996. - PubMed

LinkOut - more resources